Back

FGF-23 as a predictor of 6-month outcome and response to therapy in acute heart failure

18 March 2022 (07:45 - 19:55)
Organised by:
Congress Presentation Part of: AHF and CS - methods, predictors and interventions Biomarkers ACVC Premium Access ESC Acute CardioVascular Care 2022

About the speaker

Photo
Professor Marek Gierlotka

University of Opole, Opole (Poland)

6 More presentations in this session

Presentation thumbnail
Arrhythmia-induced cardiomyopathy: unveiled after electrical cardioversion
Doctor R. Menezes Fernandes (Faro, PT)
Abstract Slides Video
Presentation thumbnail
A novel method of approximating pressure-volume loops in the cardiac intensive care unit
Doctor A. Papolos (Washington, US)
Abstract Slides Video
Presentation thumbnail
Protective role of protein Klotho biomarker in acute heart failure
Doctor J. Plonka (Opole, PL)
Abstract Slides Video
Presentation thumbnail
Acute hemodynamic effect of ketone bodies in patients with decompensated heart failure
Doctor M. Sramko (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Predictors of non-invasive ventilation failure in adult patients with cardiac dysfunction presenting with community acquired pneumonia; an Egyptian multicenter prospective study
Assistant Professor M. Laimoud (Riyadh, SA)
Abstract Slides Video

Access the full session

Session thumbnail
AHF and CS - methods, predictors and interventions

The Event

Event poster

ESC Acute CardioVascular Care 2022

18 March - 19 March 2022
You may be interested in
thumbnail
Congress Presentation
The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure
thumbnail
Congress Presentation
State-of-the-art lecture on current state of the diagnosis of heart failure
thumbnail
Congress Session
From genetic signatures to clinical implications

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources